LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2001 | 12-2000 | 12-1999 | 12-1998 | 12-1997 | |
| Sales | 0 | 0 | 4,690 | 8,600 | 9,860 |
| Gross Profit | N/A | N/A | 4,690 | 8,600 | 9,860 |
| Operating Expenses | 27,496 | 15,639 | 14,620 | 17,690 | 17,600 |
| Operating Income | -27,496 | -15,639 | -9,930 | -9,090 | -7,740 |
| Interest Expense | 30 | 6 | 20 | 6 | 50 |
| Other Income | 2,843 | 1,846 | 810 | 1,226 | 1,430 |
| Pre-tax Income | -24,683 | -13,799 | -9,140 | -7,870 | -6,360 |
| Net Income Continuous | -24,683 | -13,799 | -9,149 | -7,877 | -6,368 |
| Net Income | $-24,683 | $-13,799 | $-9,140 | $-7,870 | $-6,360 |
| EPS Basic Total Ops | -0.71 | -0.53 | -1,125,000.00 | -1,050,000.00 | -900,000.10 |
| EPS Basic Continuous Ops | -0.71 | -0.53 | -1,126,108.00 | -1,050,934.00 | -901,132.20 |
| EPS Diluted Total Ops | -0.71 | -0.53 | -1,125,000.00 | -1,050,000.00 | -900,000.10 |
| EPS Diluted Continuous Ops | -0.71 | -0.53 | -1,126,108.00 | -1,050,934.00 | -901,132.20 |
| EBITDA(a) | $-26,695 | $-15,892 | $-9,580 | $-8,710 | $-6,980 |